Biotech startup uses nanoparticles to induce immune tolerance
Selecta Bioscience’s ImmTOR platform could improve gene therapies and prevent some drug side effects.
Selecta Bioscience’s ImmTOR platform could improve gene therapies and prevent some drug side effects.
Researchers are developing a so-called "daisy-chain" gene-drive system that provides controls for genetic engineering of certain populations.
Associate professor of chemical engineering talks about the future of biochemistry and the next generation of scientists and engineers.
New MIT technique could help decipher genes’ roles in learning and memory.
Sequencing of cancer cell genomes reveals potential new drug targets for an aggressive type of lung cancer.
Improved technique makes it easier to add or delete genes in living cells, with less risk of off-target DNA damage.
New method allows scientists to insert multiple genes in specific locations, delete defective genes.
Genetically modified organism could turn carbon dioxide or waste products into a gasoline-compatible transportation fuel.